Clinical trials in Groningen

555 clinical trials in Groningen, The Netherlands across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Groningen at a glance

555

clinical trials

Research sites8

Quick filters

555 trials in Groningen

Open in trial search

Non-small cell lung cancer stage I

Recruiting

InvestigationalNo placebo

A Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Mrna-4157
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Small cell lung cancer

Recruiting

Registered drug

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Topotecan Hydrochloride
Sponsor:Zai Lab (US) LLC

Contact Research Centre

Renal disorder

Recruiting

InvestigationalNo placebo

BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Cardiac failure+1

Recruiting

InvestigationalNo placebo

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Novo Nordisk A/S

Contact Research Centre

Focal segmental glomerulosclerosis

Recruiting

InvestigationalNo placebo

A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drug

Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

Registered drug

The Netherlands

Participants:18–64 years
Substances:Bevacizumab
Sponsor:Amgen Inc.

Contact Research Centre

Vitiligo+2

Recruiting

Investigational

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Povorcitinib
Sponsor:Incyte Corp.

Contact Research Centre

Cardiovascular disorder+2

Recruiting

Registered drugNo placebo

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Bi 690517
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Crohn's disease

Recruiting

InvestigationalNo placebo

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Tulisokibart
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Recruiting

Registered drugNo placebo

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:AstraZeneca AB

Contact Research Centre

Chronic kidney disease+1

Recruiting

Registered drugNo placebo

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:AstraZeneca AB

Contact Research Centre

Systemic scleroderma+1

Recruiting

InvestigationalNo placebo

Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Amlitelimab
Sponsor:Scleroderma Research Foundation

Contact Research Centre

555 clinical trials

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Groningen

What the registry says about research in the country

01 Cardiovascular Research

Advanced studies focusing on heart disease and cardiovascular conditions, including innovative treatments for ATTR amyloidosis and prevention strategies for heart failure.

Cardiomyopathy Treatments
Heart Failure Prevention
Peripheral Arterial Disease

Multiple trials exploring novel therapeutic approaches and preventive measures for various cardiac conditions.

02 Oncology Studies

Comprehensive research into various cancer types, including melanoma and lung cancer, with particular focus on innovative treatment approaches and metastatic disease management.

Advanced Breast Cancer
Small Cell Lung Cancer
Brain Metastases

Investigation of targeted therapies and combination treatments for improved patient outcomes.

03 Metabolic Disorders

Clinical investigations focusing on obesity and type 2 diabetes, testing new therapeutic approaches for weight management and metabolic control.

Weight Management
Diabetes Treatment
Metabolic Health

Evaluation of novel medications combined with lifestyle interventions for optimal patient care.

Back to the Netherlands All countries